Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability

NCT01928381 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Neuropathy, Painful; Diabetic Neuropathies

Interventions

DRUG: AZD5213 + pregabalin
DRUG: Placebo
DRUG: pregabalin capsules

Sponsor

AstraZeneca